Top Electric Utility Stocks To Watch Right Now

Instead of an eruption, Volcano (VOLC) got an earnings-induced collapse instead.

Associated Press

Medical-device maker Volcano said its third quarter profit would miss Wall Street forecasts, and 2013 sales would also disappoint. And 2014? Well, that didn’t look too exciting other.

JPMOrgan analyst Christopher Pasquale and team have had enough:

We are downgrading VOLC shares to Neutral from Overweight following the company’s negative 3Q preannouncement and disappointing initial 2014 growth outlook Monday after the close. While we continue to see significant long-term potential for Volcano’s technologies, we are concerned by persistent headwinds to its core IVUS franchise and slowing FFR growth. With our conviction in a pipeline-driven reacceleration reduced and visibility into meaningful new growth drivers unlikely for several quarters, we are moving to the sidelines.

Top Electric Utility Stocks To Watch Right Now: WGL Holdings Inc (WGL)

WGL Holdings, Inc. (WGL Holdings) is a holding company. The Company own subsidiaries, which sells and delivers natural gas and/or provide a range of energy-related products and services to customers in the District of Columbia and the surrounding metropolitan areas in Maryland and Virginia. The Company operates in three subsidiaries: regulated utility segment, retail energy-marketing segment and design-build energy systems segment. The Company’s wholly owned subsidiaries include Washington Gas Light Company (Washington Gas), Washington Gas Resources Corporation (Washington Gas Resources), Hampshire Gas Company (Hampshire) and Crab Run Gas Company (Crab Run). Washington Gas is a regulated public utility that sells and delivers natural gas to customers in the District of Columbia and adjoining areas in Maryland, Virginia and several cities and towns in the northern Shenandoah Valley of Virginia. Washington Gas Resources owns four subsidiaries include Washington Gas Energy Services, Inc. (WGEServices), Washington Gas Energy Systems, Inc. (WGESystems), Capitol Energy Ventures Corp. (CEV) and WGSW, Inc. (WGSW).

Regulated Utility Segment

The Company’s regulated utility segment consists of Washington Gas and Hampshire. Washington Gas delivers natural gas to retail customers. Washington Gas also sells natural gas to customers who have not elected to purchase natural gas from un-regulated third-party marketers. Washington Gas recovers the cost of the natural gas to serve firm customers through gas cost recovery mechanisms. Hampshire operates and owns full and partial interests in underground natural gas storage facilities, including pipeline delivery facilities located in and around Hampshire County, West Virginia. Washington Gas purchases all of the storage services of Hampshire and includes the cost of these services in the bills sent to its customers.

As of September 30, 2011, Washington Gas had 1 .083 million active customer meters. During the fiscal year ! ended September 30, 2011 (fiscal 2011), the Company delivered 1,772.5 million therms.

Washington Gas is responsible for acquiring sufficient natural gas supplies, interstate pipeline capacity and storage capacity. Washington Gas obtains natural gas supplies, which originate from multiple regions throughout the United States and Canada. It also obtains natural gas in the form of vaporized liquefied natural gas (LNG) through the Cove Point LNG terminal owned by Dominion Cove Point LNG, LP and Dominion Transmission, Inc. (collectively Dominion). As of September 30, 2011, Washington Gas had service agreements with four pipeline companies, which provided firm transportation and/or storage services directly to Washington Gas’s city gate.

Retail Energy-Marketing Segment

The retail energy-marketing segment consists of the operations of WGEServices, which sells the natural gas and electric commodity directly to residential, commercial and in dustrial customers. These commodities are delivered to retail customers through the distribution systems owned by regulated utilities, such as Washington Gas or other unaffiliated natural gas or electric utilities. Washington Gas delivers the natural gas sold by WGEServices, and unaffiliated electric utilities deliver all of the electricity sold. In addition, WGEServices bills its customers through the billing services of the regulated utilities, which deliver its commodities, as well as directly through its own billing capabilities. WGEServices owns multiple solar photovoltaic (Solar PV) power generating systems. As of September 30, 2011, WGEServices served approximately 172,000 residential, commercial and industrial natural gas customers accounts and approximately 183,000 residential, commercial and industrial electricity customers located in Maryland, Virginia, Delaware, Pennsylvania and the District of Columbia.

Design-Build Energy Systems Segment

The design-build energy systems segment, which consists ! of the op! erations of WGESystems, provides design-build energy solutions to governmental and commercial clients. WGESystems focuses on upgrading the mechanical, electrical, water and energy-related systems of governmental and commercial facilities by implementing both traditional, as well as alternative energy technologies, in the District of Columbia, Maryland and Virginia.

Other Activities

Other activities consist of the operations of CEV, an unregulated, non-utility subsidiary of Washington Gas Resources, which engages in the acquisition, management and optimization of natural gas storage and transportation assets and WGSW, which was formed to invest in solar power generation and other energy efficiency solutions for customers. In addition other activities include the operation of Crab Run, a small exploration company, and administrative with WGL Holdings and Washington Gas Resources. WGSW, a wholly owned subsidiary of Washington Gas Resources, holds a 99% partnership interest in ASD Solar, LP.

Advisors’ Opinion:

  • [By Lawrence Meyers]

    Today, we’ve got three lesser-known dividend stocks that have all been paying dividends for more than thirty years.

    WGL Holdings (WGL)

    The first of the secret dividend stocks is WGL Holdings (WGL), a rather unique stock in that it’s a diversified energy play. The company is split into four segments, of which two are regulated natural gas utilities, representing about 82% of the company’s total assets. The utility portions sell and deliver natural gas to some two million customers in the Washington D.C. and Virginia areas.

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on WGL Holdings (NYSE: WGL  ) , whose recent revenue and earnings are plotted below.

Top Electric Utility Stocks To Watch Right Now: Intellipharmaceutics International Inc.(IPCI)

Intellipharmaceutics International Inc. engages in the research, development, and manufacture of novel or generic controlled and targeted release oral solid dosage drugs. The company?s patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of various existing and new pharmaceuticals. It has a pipeline of products in various stages of development in therapeutic areas, including neurology, cardiovascular, and gastrointestinal tract, pain, and infection. The company?s lead generic product under development includes generic Focalin XR (dexmethylphenidate hydrochloride), an extended-release capsule for the treatment of attention deficit hyperactivity disorder. Intellipharmaceutics has a license and commercialization agreement with Par Pharmaceutical, Inc. for the development and commercialization of generic Focalin XR. The company also has five generic products filed with the FDA, including a gene r ic of Effexor XR (venlafaxine hydrochloride), an extended-release capsule for depression; Protonix (pantoprazole sodium), a delayed-release tablet for conditions associated with gastroesophageal disease; Glucophage XR (metformin hydrochloride), an extended-release tablet for managing type 2 diabetes; Seroquel XR (quetiapine fumarate), an extended-release tablet for the treatment of schizophrenia, bipolar disorder, and major depressive disorder; and Lamictal XR (lamotrigine), an extended-release tablet for the treatment of anti-convulsant for epilepsy. Its lead non-generic product under development is Rexista (oxycodone), an abuse- and alcohol-deterrent controlled-release oral oxycodone hydrochloride formulation for the relief of pain. The company also has a under late stage development product, such as Coreg CR (carvedilol phosphate), an extended-release capsule for hypertension and heart conditions. IntelliPharmaCeutics International Inc. was founded in 1998 and is based i n Toronto, Canada.

Advisors’ Opinion:

  • [By Roberto Pedone]

    A pharmaceutical player that’s starting to trend within range of triggering a big breakout trade is IntelliPharmaCeutics (IPCI), which specializing in the research, development and manufacture of generic controlled-release and targeted-release oral solid dosage drugs. This stock has been on fire over the last three months, with shares up a whopping 99%.

    If you take a look at the chart for IntelliPharmaCeutics, you’ll notice that this stock has been uptrending a bit over the last few weeks, with shares moving higher from its low f $3.12 to its recent high of $4.37 a share. During that uptrend, shares of IPCI have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of IPCI within range of triggering a big breakout trade above some key overhead resistance levels.

    Traders should now look for long-biased trades in IPCI if it manages to break out some near-term overhead resistance levels at $4.37 to $4.62 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 1.31 million shares. If that breakout triggers soon, then IPCI will set up to re-test or possibly take out its 52-week high at $6.46 a share.

    Traders can look to buy IPCI off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $3.36 or at its 50-day moving average of $3.13 a share. One could also buy IPCI off strength once it starts to take out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top Electric Utility Stocks To Watch Right Now: Grand Canyon Education Inc.(LOPE)

Grand Canyon Education, Inc. provides postsecondary education services in the United States and Canada. It focuses on offering graduate and undergraduate degree programs in education, healthcare, business, and liberal arts disciplines. The company provides its courses through traditional ground campus in Phoenix, Arizona; online; and onsite at the facilities of employers. As of December 31, 2011, it had 43,917 students enrolled in its courses. The company was formerly known as Significant Education, Inc and changed its name to Grand Canyon Education, Inc. in May 2008. Grand Canyon Education, Inc. was founded in 1949 and is based in Phoenix, Arizona.

Advisors’ Opinion:

  • [By Jeremy Bowman]

    What: Shares of Grand Canyon Education (NASDAQ: LOPE  ) were riding high today, gaining as much as 16% after soaring past estimates in its earnings report.

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on Grand Canyon Education (Nasdaq: LOPE  ) , whose recent revenue and earnings are plotted below.

Top Electric Utility Stocks To Watch Right Now: Fenner PLC (FENR)

Fenner PLC is a manufacturer and distributor of reinforced polymer products. It operates in two segments: engineered conveyor solutions, which is engaged in the manufacture of rubber, polyvinyl chloride and steel cord conveyor belts, ply, solid woven and steel cord conveyor belting for mining, power generation and industrial applications and advanced engineered products, which is engaged in the manufacture of precision polymer products; problem-solving power transmission and motion transfer components; silicone and complex hoses for heavy duty trucks, buses and off-road vehicles; seals and sealing solutions for the fluid power and oil and gas industries; technical textiles for medical and industrial applications and silicone based products for medical applications; rollers for digital image processing and medical diagnostics, and fluropolymer components for fluid and gas handling. Advisors’ Opinion:

  • [By Inyoung Hwang]

    Fenner Plc (FENR) rallied 5.2 percent to 407.4 pence, its highest price since March 20. UBS AG started coverage of the conveyor-belt maker with a buy rating, saying shares are cheap. The bank predicted the stock will climb to 460 pence in the next 12 months.

Top Electric Utility Stocks To Watch Right Now: StemCells Inc (STEM)

StemCells, Inc. (StemCells), incorporated in August 1988, is engaged in the research, development, and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The Company is focused on developing and commercializing stem and progenitor cells as the basis for therapeutics and therapies, and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. The Company’s primary research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The Company has two therapeutic product development programs, including its CNS Program, which is developing applications for HuCNS-SC cells, its human neural stem cell product candidate, and its Liver Program, which is characterizing the Company’s human liver cells as a therapeutic product.

CNS Program

The Company in its CNS Program, is in cli nical development with its HuCNS-SC cells for a range of disorders of the central nervous system. The CNS includes the brain, spinal cord and eye. In February 2012, the Company had completed a Phase I clinical trial in Pelizeaus-Merzbacher Disease (PMD), a fatal myelination disorder in the brain.

The Company’s CNS Program is focused on developing clinical applications, in which transplanting HuCNS-SC cells protect or restore organ function of the patient before such function is irreversibly damaged or lost due to disease progression. The Company’s initial target indications are PMD, and more generally, diseases in which deficient myelination plays a central role, such as cerebral palsy or multiple sclerosis; spinal cord injury, disorders in which retinal degeneration plays a central role, such as age-related macular degeneration or retinitis pigmentosa. The Company’s product candidate, HuCNS-SC cells, is a purified and expanded composition of normal human neural stem cells. Its HuCNS-SC cells can be directly transp! lanted.

Liver Program

Liver stem or progenitor cells offer an alternative treatment for liver diseases. A liver cellular therapy or cell-based therapeutic provide or support liver function in patients with liver disease. The Company held a portfolio of issued and allowed patents in the liver field, which cover the isolation and use of both hLEC cells and the isolated subset, as well as the composition of the cells themselves.

The Company’s range of cell culture products, which are sold under the SC Proven brand, includes iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff N2, and NDiff N2B27. Its iSTEM is a serum-free, feeder-free medium that maintains mouse embryonic stem cells in their pluripotent ground state by using selective small molecule inhibitors to block the pathways, which induce differentiation. RHB-A is a defined, serum-free culture medium for the selective culture of human and mouse neural stem cells and their maintenance a nd expansion as adherent cell populations. RHB-Basal is a defined, serum-free basal medium. When supplemented with specific growth factors, this media is formulated for the propagation and differentiation of adherent neural stem cells. RHB-Basal can also be tailored to specific-cell type requirements by the addition of customer preferred supplements.

The Company’s NDiff N2 is a defined serum-free scell culture supplement for the derivation, maintenance, expansion and/or differentiation of human and mouse embryonic stem (ES) cells and tissue-derived neural stem cells supplement. Its NDiff N2-AF is a serum-free and animal component-free version of NDiff N2. Its NDiff N2B27 is a defined, serum-free medium for the differentiation of mouse embryonic stem cells to neural cell types. NDiff N27-AF is a serum-free and animal component-free version of NDiff N27. Its GS1-R is a serum-free media formulation shown to enable the derivation and long-term maintenance of true, germline competent rat embryonic stem cells without the add! ition of ! cytokines or growth factors. Its GS2-M is a defined, serum- and feeder-free medium for the derivation and long-term maintenance of true, germline competent mouse iPS cells.

The Company also markets a number of antibody reagents for use in cell detection, isolation and characterization. These reagents are also under the SC Proven brand and it includes STEM24, STEM101, STEM121 and STEM123. Its STEM24 is a human antibody that recognizes human CD24, also known as heat stable antigen (HSA), a glycoprotein expressed on the surface of many human cell types, including immature human hematopoietic cells, peripheral blood lymphocytes, erythrocytes and many human carcinomas. Its CD24 is also a marker of human neural differentiation. Its STEM101 is a human-specific mouse antibody that recognizes the Ku80 protein found in human nuclei. Its STEM121 is a human-specific mouse antibody that recognizes a cytoplasmic protein of human cells. Its STEM123 is a human-specific mouse an tibody that recognizes human glial fibrillary acidic protein (GFAP).

The Company’s Other products marketed under SC Proven include total cell genomic DNA (gDNA), RNA and protein lysate reagents purified from homogenous stem cell populations for intra-comparative studies, such as Epigenetic fingerprinting, Southern, Western and Northern blots, PCR, RT-PCR and microarrays. This range of purified stem cell line lysates includes mouse embryonic stem (ES) cells propagated in SC Proven 2i inhibitor-based GS2-M media and mouse ES cell-derived and fetal tissue-derived neural stem (NS) cells propagated in SC Proven RHB-A media.

Advisors’ Opinion:

  • [By John Udovich]

    The results of a recent Pew Center Poll regarding attitudes towards abortion and various forms of stem cell research could be a good sign for the stem cell industry along with small cap stem cell stocks like StemCells Inc (NASDAQ: STEM), NeoStem Inc (NASDAQ: NBS), Neuralstem, Inc (NYSEMKT: CUR), International Stem Cell Corp (OTCMKTS: ISCO) and BioRestorative Therapies (OTCBB: BRTX). Basically, Americans think that having an abortion is a moral issue with 49% of American adults believing abortion is morally wrong, 23% view it not as a moral issue and and 15% view it as morally acceptable. However and when Americans were asked about issues surrounding human embryos, such as stem cell research or in vitro fertilization, as a matter of morality, their views were different.

  • [By James E. Brumley]

    When an investor thinks of spinal-related stem cell stocks, usually a name like Neuralstem, Inc (NYSEMKT: CUR) or StemCells Inc (NASDAQ: STEM) comes to mind. And well they should. STEM has logged some amazing breakthroughs in the field of spinal cord repair, while CUR has done the same. Not all back problems are spinal cord related though. In fact, most back problems – and therefore the most opportunity – are bone and disc related problems. That’s where a young gun like BioRestorative Therapies (OTCBB: BRTX) can step in and make stem cell waves. BRTX has developed an approach to rejuvenate and revive failing spinal discs, potentially ending pain for millions of back-pain sufferers, and circumventing expensive spinal surgeries that are in increasing burden on insurance companies.

Top Electric Utility Stocks To Watch Right Now: Iron Mountain Incorporated(IRM)

Iron Mountain Incorporated, together with its subsidiaries, provides information management services primarily in North America, Europe, Latin America, and the Asia Pacific. The company offers records management services, including records management program development and implementation based on best-practices to help customers comply with specific regulatory requirements; implementation of policy-based programs that feature storage for various media comprising paper; flexible retrieval access and retention management; hybrid services to help organizations gain control over their paper records; and specialized services for vital records and regulated industries, such as healthcare, energy, government, and financial services. It also provides data protection and recovery services, such as disaster preparedness; off-site vaulting of data backup media for data recovery in the event of a disaster, human error, or virus; online backup and recovery solutions for desktop and la ptop computers, and remote servers; and technology escrow services to protect and manage source code and other proprietary information. In addition, the company offers information destruction services that primarily consist of physical secure shredding operations; and is involved in the shredding of sensitive documents to third-party recyclers. Further, it provides fulfillment services that assemble custom marketing packages and orders, as well as provide reporting on customer marketing literature inventories; and professional consulting services to develop and implement comprehensive records and information management programs. Iron Mountain Incorporated serves commercial, legal, banking, health care, accounting, insurance, entertainment, and government organizations. The company was founded in 1951 and is headquartered in Boston, Massachusetts.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Think of Iron Mountain (IRM) as any heavy metal band after Nirvana broke in 1991. Suddenly, a way of playing music that had been wildly successful was looked at as an anachronism and bands like Metallica cut their hair, wore flannel and did just about anything they could think of to fit in in a changed world.

    Getty Images/Lonely Planet Image

    That’s Iron Mountain today. It has a business that was once fantastic–storing paper files for corporations. But in a digital world, that business is passé, even if it still brings in tons of money. Sure, Iron Mountain is doing everything it can to change its stripes–offering digital services, trying to morph into a REIT–but Iron Mountain is still what it is.

    And that’s a struggling business.

    On Friday, Iron Mountain released financial results and promptly fell 4.3%, as its earnings and revenue were in line with analyst forecasts but Iron Mountain’s North American storage growth turned negative, perhaps for the first time ever, notes Jefferies’ Dan Dolev and Trevor Young.

    So what now? Dolev and Young don’t think emerging markets can fix what ails Iron Mountain:

    It was encouraging to see international storage internal growth decelerate only slightly (-20bps to +6.3%) as it faced +70bps tougher compares…Is the strength sustainable? We are hopeful, but are not holding our breath given that 1) 4Q storage internal growth in developed international markets (e.g. Western Europe) was already below the FY average (+2.2% vs. +2.5% for the FY), and 2) although 4Q EM storage internal growth accelerated (+13.4% vs. +13.2% for the FY), history suggests that EMs can skip decades of technology evolution and upgrade directly to the newest technology (e.g. smartphones in China).

    Dolev and Young also doubt Iron Mountain’s M&A strategy. They explain why:

    With FY13 global storage internal growth 3x slower than during the Great Re

  • [By Ben Levisohn]

    Iron Mountain’s (IRM) story is now well known. Beset by a secular decline in its paper storage business, Iron Mountain has bet that a conversion into a real-estate investment trust can cure what ails it, by attracting investors interested in its potential yield. The IRS hasn’t seemed too willing to let Iron Mountain become a REIT, but the fact that it could is most likely all that stands in the way of the stock and a lower share price. And so Iron Mountain remains range bound, as investors wait to see what the IRS will do.

    Getty Images

    But maybe even the REIT conversion won’t be the savior Iron Mountain–and its investors–hope it will be. Jefferies’ Dan Dolev and team explain:

    The outcome of the IRS’ ruling is difficult to predict, but our analysis shows a potentially more muted upside and a bigger downside than many believe. A favorable ruling could trigger a short squeeze, somewhat offset by Event Driven Hedge Funds liquidating. An influx of REIT investors is possible, but our analysis shows that many already own [Iron Mountain]. Alternatively, an adverse ruling could steer attention back to weakening fundamentals, potentially leading to the P/E’s of IRM (24x) and Recall (13x) converging.

    Given an already tentative adverse ruling, the bar is high for [Iron Mountain] to convince the IRS that its racking structures are indeed real estate. The IRS would have to ignore its 1975 revenue ruling that it has relied on heavily for nearly 40 years. Even if [Iron Mountain] became a REIT, there is still no guarantee that REIT dedicated investors would buy the stock, especially given rising secular concerns.

    Shares of Iron Mountain have dropped 2.1% to $25.86 at 3:47 p.m.

  • [By Ben Levisohn]

    Iron Mountain (IRM) has bet heavily that it’s conversion to a real-estate investment trust would arrest its declining share price. But Don’t count on a permanent benefit without major changes, according to a Jefferies report released today.

    Jefferies’ Dan Dolev and Trevor Young explain:

    For many years, the durability of IRM’s paper storage business (74% of GP) has made it synonymous with stability, but our proprietary survey highlighting a dramatic decline in paper storage intentions is concerning. Data centers are a step in the right direction, but to ensure long-term viability, IRM needs a comprehensive plan to diversify away from storing paper…

    REIT status does not affect fundamentals, but a 2x dividend could bring short-term respite to the shares. Only the IRS knows if IRM would become a REIT; however, if it does, the stock would surely rise on the prospects of a $2+ dividend (~2x C-corp.).

    Dolev and Young started Iron Mountain with a Hold rating and a $27 price target. Shares of Iron Mountain have dropped 1.7% to $29 today at 2:41 p.m.

  • [By Jonathan Yates]

    But it’s events like the Missouri accident that should focus industry and investor attention on Iron Mountain (NYSE: IRM).

    Operating in the business software and services sector, along with other firms like Microsoft (NASDAQ: MSFT), CA Inc (NASDAQ: CA) and Citrix Systems (NASDAQ: CTXS), Iron Mountain is the premier company in pipeline record management. Iron Mountain plays a critical role in preventing pipeline disasters, maintaining the infrastructure and in overall risk control. The position that Iron Mountain has in the energy network will increase in scale and importance as the use of natural gas increases.

Top Electric Utility Stocks To Watch Right Now: Meritage Homes Corp (MTH)

Meritage Homes Corporation, incorporated on May 26 1988, operates as holding company. The Company through its subsidiaries is a designer and builder of single-family detached homes based on the number of home closings. The Company primarily builds in regions of the western and southern United States and offer a variety of homes that are designed to appeal to a range of homebuyers, including first-time, move-up, active adult and luxury. It has operations in three regions: West, Central and East, which consists of seven states: Arizona, California, Nevada, Texas, Colorado, Florida, and the Carolinas. Operations within the Carolinas include the Raleigh and Charlotte metropolitan areas, with some Charlotte communities located across the border into South Carolina. These three regions are its principal business segments. The Company’s homebuilding and marketing activities are conducted under the Meritage Homes brand, except for Arizona and Texas where it operates under the na me Monterey Homes. As of December 31, 2012, it was selling homes in 158 communities. Effective September 4, 2013, Meritage Homes Corporation acquired Phillips Builders Inc from Beazer Homes USA Inc.

The Company’s homes range from entry level to luxury. The Company purchases a combination of finished lots and partially-developed or undeveloped lots. As of December 31, 2012, in addition to its approximately 17,500 owned lots, it also had approximately 3,300 committed lots under option or contract. It also participates in three mortgage and one title business joint ventures. The mortgage joint ventures are engaged in mortgage activities, and they provide services to both its customers and other homebuyers. The Company acts as a general contractor.

Advisors’ Opinion:

  • [By Paul Ausick]

    Of five stocks we looked at, only one shows a gain over the past 12 months. Meritage Homes Corp. (NYSE: MTH) has a market cap of $1.68 billion and the stock closed at $45.39 last Friday, in a 52-week range of $38.42 to $52.95. The stock is up more than 8% over the past 12 months. The consensus price target is around $50.10, which indicates an implied gain of about 10%, about half the implied gain we saw in December. Meritage has easily beaten EPS in each of the past four quarters. Shares were up nearly about 0.8% at $45.82 on Monday morning. Meritage reports earnings on February 5 and is expected to post EPS of $1.03 on revenues of $537.3 million.

  • [By Ben Levisohn]

    Lee screened for stocks with low P/Es, positive net income growth, that had Overweight ratings by JPMorgan analysts and upside to analyst target prices. He found 19, including insurers MetLife (MET) and Aetna (AET), banking behemoth Wells Fargo (WFC), Meritage Homes (MTH) and hospital operator Community Health Systems (CYH).